Cite

HARVARD Citation

    Draht, M. et al. (n.d.). Promoter CpG island methylation of RET predicts poor prognosis in stage II colorectal cancer patients. Molecular oncology. 8 (3), pp. 679-688. [Online]. 
  
Back to record